These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34505754)

  • 1. Antinociceptive effects of the combined use of butorphanol and buprenorphine in mice.
    Sasaki K; Ishikawa T; Ikeda K; Kasai S
    Neuropsychopharmacol Rep; 2021 Dec; 41(4):522-525. PubMed ID: 34505754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atipamezole reverses ketamine-dexmedetomidine anesthesia without altering the antinociceptive effects of butorphanol and buprenorphine in female C57BL/6J mice.
    Izer JM; Whitcomb TL; Wilson RP
    J Am Assoc Lab Anim Sci; 2014 Nov; 53(6):675-83. PubMed ID: 25650975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An examination of the interactions between the antinociceptive effects of morphine and various mu-opioids: the role of intrinsic efficacy and stimulus intensity.
    Morgan D; Cook CD; Smith MA; Picker MJ
    Anesth Analg; 1999 Feb; 88(2):407-13. PubMed ID: 9972766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
    Fischer BD; Dykstra LA
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1300-6. PubMed ID: 16772537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure.
    Dykstra LA; Granger AL; Allen RM; Zhang X; Rice KC
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):420-9. PubMed ID: 12373443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor.
    Smith MA; Barrett AC; Picker MJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):261-9. PubMed ID: 10353428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance and cross-tolerance to the rate-suppressing effects of opioids in butorphanol-treated rats: influence of maintenance dose and relative efficacy at the mu receptor.
    Smith MA; Picker MJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):57-68. PubMed ID: 9862403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.
    Lutfy K; Eitan S; Bryant CD; Yang YC; Saliminejad N; Walwyn W; Kieffer BL; Takeshima H; Carroll FI; Maidment NT; Evans CJ
    J Neurosci; 2003 Nov; 23(32):10331-7. PubMed ID: 14614092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor.
    Cook CD; Barrett AC; Roach EL; Bowman JR; Picker MJ
    Psychopharmacology (Berl); 2000 Jul; 150(4):430-42. PubMed ID: 10958085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).
    Fischer BD; Miller LL; Henry FE; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 2008 Jun; 198(2):271-8. PubMed ID: 18392754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine exerts its antinociceptive activity via mu 1-opioid receptors.
    Kamei J; Saitoh A; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Life Sci; 1995 Mar; 56(15):PL285-90. PubMed ID: 8614238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related differences in sensitivity to the antinociceptive effects of opioids in male rats. Influence of nociceptive intensity and intrinsic efficacy at the mu receptor.
    Smith MA; Gray JD
    Psychopharmacology (Berl); 2001 Aug; 156(4):445-53. PubMed ID: 11498722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice.
    Gades NM; Danneman PJ; Wixson SK; Tolley EA
    Contemp Top Lab Anim Sci; 2000 Mar; 39(2):8-13. PubMed ID: 11487232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
    Smith MA; French AM
    Psychopharmacology (Berl); 2002 Jul; 162(3):255-64. PubMed ID: 12122483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in mu-opioid receptor knockout mice.
    Ide S; Minami M; Ishihara K; Uhl GR; Satoh M; Sora I; Ikeda K
    Neuropharmacology; 2008 Jun; 54(8):1182-8. PubMed ID: 18417173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of divalent cations on the analgesic effect of opioid and non-opioid drugs.
    Assi AA
    Pharmacol Res; 2001 Jun; 43(6):521-9. PubMed ID: 11419960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of morphine, butorphanol, buprenorphine, and U50488H on the minimum alveolar concentration of isoflurane in cats.
    Ilkiw JE; Pascoe PJ; Tripp LD
    Am J Vet Res; 2002 Aug; 63(8):1198-202. PubMed ID: 12171176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butorphanol-mediated antinociception in mice: partial agonist effects and mu receptor involvement.
    Garner HR; Burke TF; Lawhorn CD; Stoner JM; Wessinger WD
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1253-61. PubMed ID: 9316833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of buprenorphine and butorphanol analgesia in the eastern red-spotted newt (Notophthalmus viridescens).
    Koeller CA
    J Am Assoc Lab Anim Sci; 2009 Mar; 48(2):171-5. PubMed ID: 19383214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.